Helen Kitchen, MSc

Speaker Details
  • Abstract Title

    A Qualitative Study to Explore the Content Validity of the Vitiligo Patient Priority Outcome (ViPPO) Measures

  • Abstract Take Home Message

    The ViPPO-F and ViPPO-T which has been developed to evaluate the impact of facial vitiligo and total vitiligo on emotional/psychological and social functioning, has been shown to be well-understood, relevant, and comprehensive in adults and adolescents with NSV.

  • Additional Authors

    Additional Authors: Kavita Gandhi, Chloe Johnson, Kathleen W. Wyrwich, Tatjana Lukic, Tamara Al-Zubeidi, Chris Marshall, Hannah Pegram, Sharon King, Brett King.

  • Disclosures

    Helen Kitchen is an employee of and owns stock in Clarivate. Clarivate provides consultancy to various pharmaceutical and biotech companies, including Pfizer.

    Additional disclosures: Kavita Gandhi was a Pfizer employee when this study was conducted. Chloe Johnson is an employee of and owns stock in Clarivate. Clarivate provides consultancy to various pharmaceutical and biotech companies, including Pfizer. Kathleen W. Wyrwich was a Pfizer employee when this study was conducted. Tatjana Lukic is an employee of and owns stock in Pfizer. Tamara Al-Zubeidi is an employee of and owns stock in Clarivate. Clarivate provides consultancy to various pharmaceutical and biotech companies, including Pfizer. Chris Marshall is an employee of and owns stock in Clarivate. Clarivate provides consultancy to various pharmaceutical and biotech companies, including Pfizer.
    Hannah Pegram is an employee of and owns stock in Clarivate. Clarivate provides consultancy to various pharmaceutical and biotech companies, including Pfizer. Sharon King is the founder and executive director of the Litty Ligo Network. Dr. Brett King has served on advisory boards and/or is a consultant and/or is a clinical trial investigator for Aclaris Therapeutics Inc, AltruBio Inc, Almirall, Arena Pharmaceuticals, Bioniz Therapeutics, Bristol-Meyers Squibb, Concert Pharmaceuticals Inc, Dermavant Sciences Inc, Eli Lilly and Company, Incyte Corp, LEO Pharma, Otsuka/Visterra Inc, Pfizer Inc, Regeneron, Sanofi Genzyme, TWi Biotechnology Inc, and Viela Bio. He is on speaker bureaus for Pfizer Inc, Regeneron and Sanofi Genzyme.